Publication | Closed Access

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

Randomised TrialsClinical TrialsClinical DermatologyDermatologyExperimental DermatologyMedicineModerate-to-severe PsoriasisPhase 3